Skip to main content
PMC home page
Gut logoLink to Gut
. 1995 Jul;37(1):113–118. doi: 10.1136/gut.37.1.113

Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables.

E Christensen 1, C Gluud 1
PMCID: PMC1382780  PMID: 7672658

Abstract

The aim of this study was to perform a meta-analysis of controlled clinical trials of glucocorticoid treatment in clinical alcoholic hepatitis, adjusting for prognostic variables and their possible interaction with therapy, because these trials have given appreciably different results. Weighted logistic regression analysis was applied using the summarised descriptive data (for example, % with encephalopathy, mean bilirubin value) of the treatment and control groups of 12 controlled trials that gave this information. Despite evidence of publication bias favouring glucocorticoid treatment, its overall effect on mortality was not statistically significant (p = 0.20)--the relative risk (steroid/control) was 0.78 (95% confidence intervals 0.51, 1.18). There was indication of interaction between glucocorticoid therapy and gender, but not encephalopathy. Thus, the effect of glucocorticoid treatment may be different (beneficial or harmful) in special patient subgroups. These results do not support the routine use of glucocorticoids in patients with alcoholic hepatitis, including those with encephalopathy. Whether other subgroups may benefit needs further investigation using the individual patient data from the published trials and testing in new randomised trials.

Full text

PDF
116

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernard G. R., Luce J. M., Sprung C. L., Rinaldo J. E., Tate R. M., Sibbald W. J., Kariman K., Higgins S., Bradley R., Metz C. A. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987 Dec 17;317(25):1565–1570. doi: 10.1056/NEJM198712173172504. [DOI] [PubMed] [Google Scholar]
  2. Blitzer B. L., Mutchnick M. G., Joshi P. H., Phillips M. M., Fessel J. M., Conn H. O. Adrenocorticosteroid therapy in alcoholic hepatitis. A prospective, double-blind randomized study. Am J Dig Dis. 1977 Jun;22(6):477–484. doi: 10.1007/BF01072499. [DOI] [PubMed] [Google Scholar]
  3. Bories P., Guedj J. Y., Mirouze D., Yousfi A., Michel H. Traitement de l'hépatite alcoolique aiguë par la prednisolone. Quarante-cinq malades. Presse Med. 1987 May 2;16(16):769–772. [PubMed] [Google Scholar]
  4. Campra J. L., Hamlin E. M., Jr, Kirshbaum R. J., Olivier M., Redeker A. G., Reynolds T. B. Prednisone therapy of acute alcoholic hepatitis. Report of a controlled trial. Ann Intern Med. 1973 Nov;79(5):625–631. doi: 10.7326/0003-4819-79-5-625. [DOI] [PubMed] [Google Scholar]
  5. Carithers R. L., Jr, Herlong H. F., Diehl A. M., Shaw E. W., Combes B., Fallon H. J., Maddrey W. C. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med. 1989 May 1;110(9):685–690. doi: 10.7326/0003-4819-110-9-685. [DOI] [PubMed] [Google Scholar]
  6. Chalmers T. C., Smith H., Jr, Blackburn B., Silverman B., Schroeder B., Reitman D., Ambroz A. A method for assessing the quality of a randomized control trial. Control Clin Trials. 1981 May;2(1):31–49. doi: 10.1016/0197-2456(81)90056-8. [DOI] [PubMed] [Google Scholar]
  7. Christensen E. Individual therapy-dependent prognosis based on data from controlled clinical trials in chronic liver disease. Dan Med Bull. 1988 Apr;35(2):167–182. [PubMed] [Google Scholar]
  8. Christensen E. Multivariate survival analysis using Cox's regression model. Hepatology. 1987 Nov-Dec;7(6):1346–1358. doi: 10.1002/hep.1840070628. [DOI] [PubMed] [Google Scholar]
  9. Christensen E., Schlichting P., Andersen P. K., Fauerholdt L., Juhl E., Poulsen H., Tygstrup N. A therapeutic index that predicts the individual effects of prednisone in patients with cirrhosis. Gastroenterology. 1985 Jan;88(1 Pt 1):156–165. doi: 10.1016/s0016-5085(85)80148-7. [DOI] [PubMed] [Google Scholar]
  10. Conn H. O. Steroid treatment of alcoholic hepatitis. The yeas and the nays. Gastroenterology. 1978 Feb;74(2 Pt 1):319–322. [PubMed] [Google Scholar]
  11. Daures J. P., Peray P., Bories P., Blanc P., Yousfi A., Michel H., Gremy F. Place de la corticothérapie dans le traitement des hépatites alcooliques aiguës. Résultats d'une méta-analyse. Gastroenterol Clin Biol. 1991;15(3):223–228. [PubMed] [Google Scholar]
  12. Depew W., Boyer T., Omata M., Redeker A., Reynolds T. Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy. Gastroenterology. 1980 Mar;78(3):524–529. [PubMed] [Google Scholar]
  13. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 Sep;7(3):177–188. doi: 10.1016/0197-2456(86)90046-2. [DOI] [PubMed] [Google Scholar]
  14. Helman R. A., Temko M. H., Nye S. W., Fallon H. J. Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy. Ann Intern Med. 1971 Mar;74(3):311–321. doi: 10.7326/0003-4819-74-3-311. [DOI] [PubMed] [Google Scholar]
  15. Hofer T., McMahon L. Corticosteroids and alcoholic hepatitis. Hepatology. 1991 Jan;13(1):199–201. doi: 10.1002/hep.1840130132. [DOI] [PubMed] [Google Scholar]
  16. Imperiale T. F., McCullough A. J. Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. Ann Intern Med. 1990 Aug 15;113(4):299–307. doi: 10.7326/0003-4819-113-4-299. [DOI] [PubMed] [Google Scholar]
  17. L'Abbé K. A., Detsky A. S., O'Rourke K. Meta-analysis in clinical research. Ann Intern Med. 1987 Aug;107(2):224–233. doi: 10.7326/0003-4819-107-2-224. [DOI] [PubMed] [Google Scholar]
  18. Lesesne H. R., Bozymski E. M., Fallon H. J. Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements. Gastroenterology. 1978 Feb;74(2 Pt 1):169–173. [PubMed] [Google Scholar]
  19. Maddrey W. C., Boitnott J. K., Bedine M. S., Weber F. L., Jr, Mezey E., White R. I., Jr Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 1978 Aug;75(2):193–199. [PubMed] [Google Scholar]
  20. Mendenhall C. L., Anderson S., Garcia-Pont P., Goldberg S., Kiernan T., Seeff L. B., Sorrell M., Tamburro C., Weesner R., Zetterman R. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med. 1984 Dec 6;311(23):1464–1470. doi: 10.1056/NEJM198412063112302. [DOI] [PubMed] [Google Scholar]
  21. Ramond M. J., Poynard T., Rueff B., Mathurin P., Théodore C., Chaput J. C., Benhamou J. P. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med. 1992 Feb 20;326(8):507–512. doi: 10.1056/NEJM199202203260802. [DOI] [PubMed] [Google Scholar]
  22. Shumaker J. B., Resnick R. H., Galambos J. T., Makopour H., Iber F. L. A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patients. Am J Gastroenterol. 1978 Apr;69(4):443–449. [PubMed] [Google Scholar]
  23. Theodossi A., Eddleston A. L., Williams R. Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis. Gut. 1982 Jan;23(1):75–79. doi: 10.1136/gut.23.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Thompson S. G. Controversies in meta-analysis: the case of the trials of serum cholesterol reduction. Stat Methods Med Res. 1993;2(2):173–192. doi: 10.1177/096228029300200205. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES